keyword
https://read.qxmd.com/read/38398748/the-impact-of-probiotic-bifidobacterium-on-liver-diseases-and-the-microbiota
#1
REVIEW
Gabriel Henrique Hizo, Pabulo Henrique Rampelotto
Recent studies have shown the promising potential of probiotics, especially the bacterial genus Bifidobacterium , in the treatment of liver diseases. In this work, a systematic review was conducted, with a focus on studies that employed advanced Next Generation Sequencing (NGS) technologies to explore the potential of Bifidobacterium as a probiotic for treating liver pathologies such as Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH), Alcoholic Liver Disease (ALD), Cirrhosis, and Hepatocelullar Carcinoma (HCC) and its impact on the microbiota...
February 8, 2024: Life
https://read.qxmd.com/read/38116022/genomic-variations-between-fibrolamellar-and-conventional-hepatocellular-carcinomas
#2
JOURNAL ARTICLE
Bengi Öztürk
Aim The aim of this study is to define genomic variations between fibrolamellar hepatocellular carcinoma (FL-HCC) and conventional hepatocellular carcinoma (HCC) Methods This study used the American Association for Cancer Research (AACR) Project GENIE data as a foundational element. Specifically, information about both fibrolamellar and conventional hepatocellular carcinoma was retrieved from this database. Results A total of 719 patients diagnosed with HCC and 52 individuals presenting with FL-HCC underwent thorough analysis...
December 2023: Curēus
https://read.qxmd.com/read/32041922/is-higher-bmi-associated-with-worse-overall-mortality-in-hepatocellular-carcinoma-patients-an-evidence-based-case-report
#3
JOURNAL ARTICLE
Alessa Fahira, Ratu Shafira Hanifah, Mohamad Prasetio Wardoyo, Amirah Deandra Diba, Rahadian Ramadhan, Julie Dewi Barliana, Chyntia Olivia Jasirwan
BACKGROUND: liver cancer is currently the second deadliest cancer in the world with hepatocelullar carcinoma (HCC) being the commonest form-accounting 90% of all its cases. With the current global alarming increase of obesity, there is hence an increase of fatty liver disease cases, which is one of the major non-viral etiology of cirrhosis in the world. The objective of this study is to evaluate whether obese HCC patients have worse survival outcome. METHODS: PubMed, Cochrane, Scopus, ProQuest, and EBSCOhost were comprehensively searched for systematic review and cohort prognostic researches studying overall survival of HCC patients who are underweight and obesity according to their BMI...
October 2019: Acta Medica Indonesiana
https://read.qxmd.com/read/31253209/diagnostic-accuracy-of-doppler-ultrasonography-in-predicting-presence-of-esophageal-varices-in-patients-with-hepatitis-c-induced-cirrhosis
#4
JOURNAL ARTICLE
Ali Mansoor, Rabia Shaukat, Aamer Nadeem Chaudhary, Gohar Jehan
OBJECTIVE: To determine the diagnostic accuracy of Doppler ultrasonography in predicting presence of esophageal varices in patients with hepatitis-C induced cirrhosis. STUDY DESIGN: Descriptive analytical study. PLACE AND DURATION OF STUDY: Department of Radiology, Jinnah Hospital, Lahore, from May 2016 to October 2016. METHODOLOGY: Patients aged 15-70 years, who presented with cirrhosis and proved to be cirrhosis caused by Hepatitis-C of any gender and duration of disease more than 6 months, were included...
July 2019: Journal of the College of Physicians and Surgeons—Pakistan: JCPSP
https://read.qxmd.com/read/30929334/-consensus-on-clinical-application-of-transient-elastography-detecting-liver-fibrosis-a-2018-update
#5
JOURNAL ARTICLE
(no author information available yet)
Transient elastography is a noninvasive, rapid ultrasonic elastography, and assess liver fibrosis by detetcting liver stiffness. Current consensus focuses on understanding influence factors on operation and diagnosis, recommendations for clinical application on detetcting liver fibrosis of chronic liver disease and monitoring development of related complication hepatocelullar carcinoma, high risk esophageal varices, and also summarizes the potential aplication on liver disease screening and liver fibrosis regression assessment...
March 20, 2019: Zhonghua Gan Zang Bing za Zhi, Zhonghua Ganzangbing Zazhi, Chinese Journal of Hepatology
https://read.qxmd.com/read/28776383/hepatocellular-carcinoma-in-patients-without-advanced-fibrosis-after-hcv-eradication-antiviral-treatment
#6
JOURNAL ARTICLE
Yolanda Sánchez-Torrijos, Jara Eloísa Ternero Vega, Carmen Cepeda Franco
From the last few years, hepatitis C virus and the new direct antiviral treatments are being more and more important. In consequence, case studies like the one we present, the appearance of hepatocelullar carcinoma after its eradication with fibrosis grade 2, are getting special interest. In 2007, our patient was treated with pegylated interferon α-2a and ribavirin, having a sustained virological response after it. In this way, liver fibrosis grade 2 was confirmed by a biopsy. Finally, after corroborating a good liver functioning, the patient was discharged (as, according to the guidebooks, an ultrasound scan of screeing every 6 months was not required)...
October 2017: Revista Española de Enfermedades Digestivas
https://read.qxmd.com/read/28611272/a-case-report-of-hepatocellular-carcinoma-5-years-after-hbsag-loss-in-chronic-hepatitis-delta-how-long-surveillance-is-required
#7
JOURNAL ARTICLE
Laura Escolà-Vergé, Mar Riveiro-Barciela, Maria Buti
BACKGROUND: Hepatitis delta virus infection occurs as acute co-infection or as superinfection in patients with preexisting chronic hepatitis B. Chronic hepatitis delta leads to more severe disease than chronic hepatitis B, with more rapid progression of fibrosis and increased risk of hepatocelullar carcinoma. CASE REPORT: We report a case of hepatocelullar carcinoma 5 years after spontaneous clearance of Hepatitis B surface antigen in a patient with previous chronic hepatitis delta...
2017: Annals of Hepatology
https://read.qxmd.com/read/27598745/systemic-treatment-for-advanced-hepatocellular-carcinoma-the-search-of-new-agents-to-join-sorafenib-in-the-effective-therapeutic-armamentarium
#8
REVIEW
Andrea Ribeiro de Souza, Maria Reig, Jordi Bruix
INTRODUCTION: Hepatocelullar carcinoma (HCC) is the third leading cause of cancer-related death worldwide. Despite the implementation of screening programs for high-risk individuals, a significant proportion of patients present with advanced disease at the moment of diagnosis. AREAS COVERED: In this review we will focus in the current treatment of advanced HCC, the research that has been done in the past few years, the achievements and failures in this setting and future perspectives...
October 2016: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/27303576/prevalence-of-hbsag-knowledge-and-vaccination-practice-against-viral-hepatitis-b-infection-among-doctors-and-nurses-in-a-secondary-health-care-facility-in-lagos-state-south-western-nigeria
#9
JOURNAL ARTICLE
Abdul-Hakeem Olatunji Abiola, Adebukola Bola Agunbiade, Kabir Bolarinwa Badmos, Adenike Olufunmilayo Lesi, Abdulrazzaq Oluwagbemiga Lawal, Quadri Olatunji Alli
INTRODUCTION: Hepatitis B Virus, a highly infectious blood-borne virus poses a major threat to public health globally due to its high prevalence rate and grave consequence in causing liver cirrhosis and hepatocelullar carcinoma, the third cause of cancer death worldwide. The aim is determine the prevalence of HBsAg, knowledge, and vaccination practices against viral hepatitis B infection among doctors and nurses in a health care facility. METHODS: Study design was a descriptive cross-sectional study among all the doctors and nurses in the health care facility...
2016: Pan African Medical Journal
https://read.qxmd.com/read/27084592/unexpected-high-rate-of-early-tumor-recurrence-in-patients-with-hcv-related-hcc-undergoing-interferon-free-therapy
#10
JOURNAL ARTICLE
María Reig, Zoe Mariño, Christie Perelló, Mercedes Iñarrairaegui, Andrea Ribeiro, Sabela Lens, Alba Díaz, Ramón Vilana, Anna Darnell, María Varela, Bruno Sangro, José Luis Calleja, Xavier Forns, Jordi Bruix
BACKGROUND & AIMS: The success of direct-acting antivirals (DAA) against hepatitis C is a major breakthrough in hepatology. Until now, however, there are very few data on the effect of hepatitis C virus (HCV) eradication in patients who have already developed hepatocellular carcinoma. METHODS: The study included patients with HCV infection and prior history of treated hepatocellular carcinoma who achieved complete response and lacked 'non-characterized nodules' at the time they underwent anti-HCV treatment with all-oral DAAs in 4 hospitals...
October 2016: Journal of Hepatology
https://read.qxmd.com/read/24898491/-a-case-of-intraventricular-dissemination-arising-from-hepatocelullar-carcinoma-effectively-treated-with-intrathecal-administration-of-methotrexate
#11
JOURNAL ARTICLE
Hikaru Oguri, Masaki Miyazawa, Tomoki Nishikawa, Shinichi Hayashi
A 78-year-old man with hepatocellular carcinoma was admitted to our hospital for vertigo after transcatheter arterial chemoembolization. Contrast-enhanced magnetic resonance imaging revealed metastasis in the cerebellar vermis. Although the cerebellar metastasis decreased in size after cyberknife radiotherapy, multiple enhancing nodules appeared in the cerebral ventricles. A diagnosis of intraventricular dissemination from the cerebellar metastatic lesion originating from the hepatocellular carcinoma was made...
June 2014: Nihon Shokakibyo Gakkai Zasshi, the Japanese Journal of Gastro-enterology
https://read.qxmd.com/read/24355442/evaluation-of-five-dna-extraction-methods-for-detection-of-h-pylori-in-formalin-fixed-paraffin-embedded-ffpe-liver-tissue-from-patients-with-hepatocellular-carcinoma
#12
COMPARATIVE STUDY
Elizabeth Rabelo-Gonçalves, Bruna Roesler, Ana Carolina Guardia, Arlete Milan, Natalicia Hara, Cecília Escanhoela, Jazon Almeida, Ilka Boin, José Murilo Zeitune
Since Helicobacter spp. DNA was identified in liver tissue resected from patients with hepatocelullar carcinoma (HCC), researchers have suggested a role of this bacterium in hepatic carcinogenesis. Archives of formalin-fixed, paraffin-embedded (FFPE) tissues represent an extraordinary source for clinical studies providing many advantages. However, DNA extraction from FFPE tissues is laborious, time-consuming and still remains a challenge. The aim of this study was to evaluate five protocols for DNA extraction from FFPE liver obtained from patients with HCC in order to detect Helicobacter pylori DNA...
March 2014: Pathology, Research and Practice
https://read.qxmd.com/read/24159584/comparison-of-international-guidelines-for-noninvasive-diagnosis-of-hepatocellular-carcinoma
#13
REVIEW
Simona Bota, Fabio Piscaglia, Sara Marinelli, Anna Pecorelli, Eleonora Terzi, Luigi Bolondi
The aim of this review is to present the similarities and differences between the latest guidelines for noninvasive diagnosis of hepatocelullar carcinoma (HCC) of American Association for the Study of Liver Diseases (AASLD), European Association for the Study of the Liver (EASL), Asian Pacific Association for the Study of the Liver (APASL), and Japanese Society of Hepatology. All the four guidelines defined a typical HCC vascular pattern as the homogeneous hyperenhancement (wash-in) in the arterial phase followed by wash-out in the venous or late phase...
November 2012: Liver Cancer
https://read.qxmd.com/read/22983078/influence-of-the-sorafenib-patients-assistance-program-on-treatment-compliance-and-overall-survival-of-unresectable-hepatocellular-carcinoma-patients
#14
JOURNAL ARTICLE
Laurentius A Lesmana, Rino A Gani, Irsan Hasan, Agus Waspodo, Poernomo Boedi, Melissa S Luwia, Adityawati Ganggaiswari
AIM: to evaluate treatment compliance and survival of patients receiving oral sorafenib in Indonesia. METHODS: a prospective cohort trial. Unresectable Hepatocelullar carcinoma patients receiving Sorafenib in NexPAP program were recruited between October 2008 and September 2011. A historical cohort from Cipto Mangunkusumo Hospital, between 1998 and 2000 was selected to serve as control group. Patients in the control group received symptomatic treatment. Survival analysis was done by the Kaplan-Meier survival curve analysis and the log-rank test...
July 2012: Acta Medica Indonesiana
https://read.qxmd.com/read/21645963/treatment-of-small-hepatocellular-carcinomas-with-us-guided-high-intensity-focused-ultrasound
#15
JOURNAL ARTICLE
Hiroyuki Fukuda, Ryu Ito, Masao Ohto, Akio Sakamoto, Eii Karasawa, Taketo Yamaguchi, Norihiro Shinozuka, Hui Zhu, Zhi-Biao Wanga
High-intensity focused ultrasound (HIFU) is a noninvasive method that can cause complete coagulation necrosis without requiring the insertion of any instruments. The purpose of this study was to evaluate the safety and efficacy of HIFU treatment for small liver cancers without performing transcatheter arterial chemoembolization (TACE) or rib resection. HIFU ablation was performed without rib resection or the aid of TACE or percutaneous ethanol injection (PEI) in 12 patients with hepatocelullar carcinoma. The HIFU system (Chongqing Haifu Tech, Chongqing, China) was used under ultrasound guidance...
August 2011: Ultrasound in Medicine & Biology
https://read.qxmd.com/read/21484121/hbv-a-and-hbv-c-genotype-predominance-among-patients-with-chronic-hepatitis-b-virus-infection-in-cebu-city-philippines
#16
JOURNAL ARTICLE
Karen S Batoctoy, Tai-Chung Tseng, Jia-Horng Kao, Fidelis E Quiza, Lamberto H Garcia, Judy Lao-Tan
CONTEXT: Chronic Hepatitis B virus (HBV) infection causes significant morbidity and mortality with widespread global distribution. Different genotypes display variations in pathogenesis, disease behavior, and treatment response. HBV/B and HBV/C are prevalent in Asia, but minimal data come from the Philippines. OBJECTIVE: This study is aimed to determine the HBV genotypes of Filipino patients with Chronic HBV infection seen in Cebu City, Philippines and describe the age, sex, viral activity, alanine aminotransferase (ALT) levels and viral load patterns by genotype...
September 2011: Hepatology International
https://read.qxmd.com/read/20149473/clinical-outcomes-of-radiofrequency-ablation-percutaneous-alcohol-and-acetic-acid-injection-for-hepatocelullar-carcinoma-a-meta-analysis
#17
COMPARATIVE STUDY
Giacomo Germani, Maria Pleguezuelo, Kurinchi Gurusamy, Tim Meyer, Graziella Isgrò, Andrew Kenneth Burroughs
BACKGROUND & AIMS: Radiofrequency ablation (RFA) is often the preferred local ablation therapy for hepatocellular carcinoma (HCC). Percutaneous ethanol injection (PEI) is less frequently used, and percutaneous acetic acid injection (PAI) has been mostly abandoned. Robust evidence showing benefit of one therapy versus another is lacking. Our aim was to evaluate the evidence comparing RFA, PEI and PAI using meta-analytical techniques. METHODS: Literature search was undertaken until December 2008 to identify comparative studies evaluating survival, recurrence, complete necrosis of tumour and complications...
March 2010: Journal of Hepatology
https://read.qxmd.com/read/20055297/-transarterial-chemoembolization-in-hepatocellular-carcinoma
#18
JOURNAL ARTICLE
M Varga, A Valsamis, I Matia, J Peregrin, E Honsová, M Safanda, M Oliverius
INTRODUCTION: Hepatocelullar carcinoma (HCC) is the fifth most common cancer in the world. It mostly occurs in patients with cirrhosis. In the Czech Republic, about 250 new cases are reported per year. Surgery, i.e. liver resection or transplantation, as the only potentially curable method is possible in 15-20% of them. For the rest, palliative treatment is indicated. This includes ablative methods (radiofrequency ablation, alcoholization), transarterial chemoembolization (TACE), systemic chemotherapy or biological treatment by sorafenib...
August 2009: Rozhledy V Chirurgii: Měsíčník Československé Chirurgické Společnosti
https://read.qxmd.com/read/19864776/superiority-of-laparoscopic-guided-needle-biopsy-over-percutaneous-blind-needle-biopsy-in-diagnosing-hepatocellular-carcinoma-associated-with-cirrhosis
#19
JOURNAL ARTICLE
A H Al-Saigh
This is a retrospective study of 40 patients clinically suspected of having hepatocellular carcinoma. Group 1 (20) patients underwent laparoscopic Tru-cut needle liver biopsy and Group II (20 patients) underwent percutaneous blind needle liver biopsy. In the first group, in 17 (85%) of the patients, the diagnosis of hepatocellular carcinoma was confirmed by histopathology, direct observation of cirrhosis was seen in 8 (40%) patients, histopathology confirmation of cirrhosis was documented in 6 (35%) patients...
May 1998: Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association
https://read.qxmd.com/read/18351237/-liver-transplatation-for-malignant-tumors-in-children
#20
JOURNAL ARTICLE
L F Avila, J L Encinas, N Leal, A Guinea, P García Miguel, P Jara, J Murcia, M Gamez, A Guinea, M López Santamaría, J A Tovar
OBJECTIVE: To analyse our results on liver transplantation (LTX) in primitive malignant unresectable liver tumours in children and discussing its controversial indications in order to our experience. METHODS/PATIENTS: We report 12 patients with ages ranging from 6 months to 14 years old. They had hepatoblastoma (11) and fibrolamellar hepatocelullar carcinoma (1) without cirrhosis. LTX was considered as primary treatment in 10 patients (PRETEXT IV or any grade if extension to retrohepatic cava vein, 3 hepatic veins or porta vein were assessed) and as rescue therapy after recurrence (1) or persistence of unresectable macroscopic rests (2)...
October 2007: Cirugía Pediátrica: Organo Oficial de la Sociedad Española de Cirugía Pediátrica
keyword
keyword
99969
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.